Author:
Comoglio P. M.,Direnzo M. F.,Gaudino G.,Giordano S.,Naldini L.,Ponzetto C.
Publisher
Springer Berlin Heidelberg
Reference118 articles.
1. Anastasi A, Erspamer V, Bucci M (1971) Isolation and structure of bombesin and alytesin, two analogous active peptides from the skin of the European amphibian bombina and alytes. Exper-ientia 27:166–167
2. Bartram CR, Kleihauer E, de Klein A, Grosveld G, Teyssier JR, Heisterkamp N, Groffen J (1986) C-abl and bcr are rearranged in a Ph1-negative CML patient. EMBO J 4:683–686
3. Ben-Neriah Y, Baltimore D (1986) Normal and transforming N-terminal variants of c-abl. In: Kahn P, Graf T (eds) Oncogene and growth control. Springer, Berlin Heidelberg New York, pp 106–114
4. Ben-Neriah Y, Daley GQ, Mes-Masson AM, Witte ON, Baltimore D (1986a) The chronic myelogenous leukemia-specific P210 proteins is the product of the bcr/abl hybrid gene. Science 233:212–214
5. Ben-Neriah Y, Bernards A, Paskind M, Daley GQ, Baltimore D (1986b) Alternative 5′ exons in c-abl mRNA. Cell 44:577–586